1. Home
  2. MREO vs CIA Comparison

MREO vs CIA Comparison

Compare MREO & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • CIA
  • Stock Information
  • Founded
  • MREO 2015
  • CIA 1969
  • Country
  • MREO United Kingdom
  • CIA United States
  • Employees
  • MREO N/A
  • CIA N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • CIA Life Insurance
  • Sector
  • MREO Health Care
  • CIA Finance
  • Exchange
  • MREO Nasdaq
  • CIA Nasdaq
  • Market Cap
  • MREO 311.8M
  • CIA 261.8M
  • IPO Year
  • MREO N/A
  • CIA N/A
  • Fundamental
  • Price
  • MREO $2.16
  • CIA $5.53
  • Analyst Decision
  • MREO Strong Buy
  • CIA
  • Analyst Count
  • MREO 5
  • CIA 0
  • Target Price
  • MREO $7.40
  • CIA N/A
  • AVG Volume (30 Days)
  • MREO 1.4M
  • CIA 107.1K
  • Earning Date
  • MREO 11-11-2025
  • CIA 11-06-2025
  • Dividend Yield
  • MREO N/A
  • CIA N/A
  • EPS Growth
  • MREO N/A
  • CIA N/A
  • EPS
  • MREO N/A
  • CIA 0.22
  • Revenue
  • MREO $500,000.00
  • CIA $245,943,000.00
  • Revenue This Year
  • MREO N/A
  • CIA $4.22
  • Revenue Next Year
  • MREO $72.16
  • CIA $4.46
  • P/E Ratio
  • MREO N/A
  • CIA $25.23
  • Revenue Growth
  • MREO N/A
  • CIA N/A
  • 52 Week Low
  • MREO $1.47
  • CIA $2.90
  • 52 Week High
  • MREO $4.72
  • CIA $6.08
  • Technical
  • Relative Strength Index (RSI)
  • MREO 61.75
  • CIA 50.17
  • Support Level
  • MREO $1.94
  • CIA $5.70
  • Resistance Level
  • MREO $2.28
  • CIA $6.08
  • Average True Range (ATR)
  • MREO 0.12
  • CIA 0.24
  • MACD
  • MREO 0.01
  • CIA 0.01
  • Stochastic Oscillator
  • MREO 65.53
  • CIA 45.23

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About CIA Citizens Inc. ($1.00 Par)

Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.

Share on Social Networks: